Association of patient weight status with plasma surfactant protein D, a biomarker of alveolar epithelial injury, in children with acute respiratory failure.

acute respiratory distress syndrome acute respiratory failure alveolar epithelial injury body mass index children mechanical ventilation obesity pediatric surfactant protein D

Journal

Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590

Informations de publication

Date de publication:
10 2020
Historique:
received: 02 06 2020
revised: 24 07 2020
accepted: 27 07 2020
pubmed: 30 7 2020
medline: 2 3 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

Alveolar epithelial injury is a key determinant of acute respiratory failure (ARF) severity. Plasma surfactant protein D (SP-D), a biomarker of alveolar epithelial injury, is lower in obese adults with ARF compared to their lean peers. We aimed to determine if children with ARF have similar variance in plasma SP-D associated with their weight status on admission. Plasma SP-D was measured on days 0, 1, or 2 in children (1-18 years) with ARF enrolled in the genetic variation and biomarkers in children with acute lung injury and RESTORE studies. Weight classification (underweight, normal, overweight, and obese) was based on body mass index or weight-for-height z-scores. Associations between weight group and SP-D on each day were tested. Inclusion criteria were met in 212 subjects, 24% were obese. There were no differences among weight groups in SP-D levels on days 0 and 1. However, on day 2, there was a statistically significant linear trend for lower SP-D levels as weight increased in both the univariate analysis (P = .02) and when adjusting for age, ethnicity, and diagnosis of pediatric acute respiratory distress syndrome (P = .05). Obesity was associated with lower plasma SP-D levels on day 2 of ARF. This finding may be explained by altered ARF pathogenesis in obese individuals or a reduced incidence of ventilator-induced lung injury.

Identifiants

pubmed: 32725941
doi: 10.1002/ppul.24990
pmc: PMC8087214
mid: NIHMS1644035
doi:

Substances chimiques

Biomarkers 0
Pulmonary Surfactant-Associated Protein D 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2730-2736

Subventions

Organisme : NICHD NIH HHS
ID : R01 HD092471
Pays : United States
Organisme : NICHD NIH HHS
ID : HD092471
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL086622
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL086649
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL0114484
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL095410
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL140026
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL095410
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL114484
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL086649
Pays : United States
Organisme : NICHD NIH HHS
ID : K12HD047349
Pays : United States
Organisme : NICHD NIH HHS
ID : K12 HD047349
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL140026
Pays : United States
Organisme : NHLBI NIH HHS
ID : HL086622
Pays : United States

Informations de copyright

© 2020 Wiley Periodicals LLC.

Références

Pediatr Crit Care Med. 2007 Jul;8(4):317-23
pubmed: 17545931
Stat Med. 1985 Jan-Mar;4(1):87-90
pubmed: 3992076
Dis Markers. 2012;32(5):281-7
pubmed: 22674408
Nat Rev Dis Primers. 2019 Mar 14;5(1):18
pubmed: 30872586
Thorax. 2003 Nov;58(11):983-8
pubmed: 14586055
Ann Intensive Care. 2016 Dec;6(1):114
pubmed: 27873291
J Appl Physiol (1985). 2010 Jan;108(1):212-8
pubmed: 19910329
Pediatr Crit Care Med. 2018 Oct;19(10):930-938
pubmed: 30095747
BMC Pulm Med. 2010 Feb 16;10:6
pubmed: 20158912
N Engl J Med. 2000 May 4;342(18):1301-8
pubmed: 10793162
Pediatr Crit Care Med. 2010 Jan;11(1):82-91
pubmed: 19550365
PLoS One. 2012;7(4):e35066
pubmed: 22509382
Crit Care. 2019 Apr 17;23(1):128
pubmed: 30995942
J Pediatr. 1997 Oct;131(4):575-81
pubmed: 9386662
Crit Care Med. 2016 Nov;44(11):2052-2059
pubmed: 27355525
Chest. 2015 Jun;147(6):1539-1548
pubmed: 26033126
Pediatr Crit Care Med. 2015 Jun;16(5):428-39
pubmed: 25647235
Mol Immunol. 2006 Mar;43(9):1293-315
pubmed: 16213021
Clin Chim Acta. 1997 Oct 31;266(2):157-71
pubmed: 9437544
Int J Obes (Lond). 2013 Dec;37(12):1532-8
pubmed: 23478426
Pediatr Crit Care Med. 2017 Jan;18(1):e48-e55
pubmed: 28060170
Am J Respir Crit Care Med. 2005 May 1;171(9):995-1001
pubmed: 15618461
Chest. 2020 Sep;158(3):1027-1035
pubmed: 32275979
J Appl Physiol. 1970 May;28(5):596-608
pubmed: 5442255
Am J Respir Crit Care Med. 1999 Dec;160(6):1843-50
pubmed: 10588595
Vital Health Stat 11. 2002 May;(246):1-190
pubmed: 12043359
Biochim Biophys Acta. 1998 Nov 19;1408(2-3):278-89
pubmed: 9813367
Chest. 2010 Feb;137(2):288-96
pubmed: 19858233
Thorax. 2010 Jan;65(1):44-50
pubmed: 19770169
Chest. 2010 Sep;138(3):568-77
pubmed: 20435656
Chest. 2007 Feb;131(2):342-8
pubmed: 17296631
Lancet Respir Med. 2019 Feb;7(2):115-128
pubmed: 30361119
Pediatr Pulmonol. 2014 Oct;49(10):1003-10
pubmed: 24167154
J Ayub Med Coll Abbottabad. 2016 Jul-Sep;28(3):489-492
pubmed: 28712219
Crit Care Med. 2011 Apr;39(4):711-7
pubmed: 21283009
JAMA. 2015 Jan 27;313(4):379-89
pubmed: 25602358
Trends Microbiol. 2015 Dec;23(12):799-811
pubmed: 26482345
BMC Pulm Med. 2017 Dec 15;17(1):204
pubmed: 29246207
Scand J Immunol. 2006 Dec;64(6):633-8
pubmed: 17083619
Crit Care Med. 2006 Mar;34(3):738-44
pubmed: 16521268
Pediatrics. 2007 Dec;120 Suppl 4:S164-92
pubmed: 18055651
Scand J Immunol. 2007 Jul;66(1):71-76
pubmed: 17587348

Auteurs

Shan L Ward (SL)

Division of Critical Care, Department of Pediatrics, UCSF Benioff Children's Hospitals, San Francisco and Oakland, California.

Mary K Dahmer (MK)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.

Heidi M Weeks (HM)

Department of Nutritional Sciences, University of Michigan School of Public Health, Ann Arbor, Michigan.

Anil Sapru (A)

Division of Critical Care Medicine, Department of Pediatrics, Mattel Children's Hospital at UCLA Medical Center, Los Angeles, California.

Michael W Quasney (MW)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.

Martha A Q Curley (MAQ)

Division of Anesthesia and Critical Care Medicine, Department of Family and Community Health, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Children's Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania.

Kathleen D Liu (KD)

Department of Medicine, UCSF Medical Center, San Francisco, California.

Michael A Matthay (MA)

Department of Anesthesia, UCSF Medical Center, San Francisco, California.
UCSF Medical Center, Cardiovascular Research Institute, San Francisco, California.

Heidi R Flori (HR)

Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Michigan, Ann Arbor, Michigan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH